β³ Fetching live dividend data...
Home βΊ Calculator βΊ PETQ Dividend Calculator 2026
PetIQ, Inc. Β· NASDAQ
Price: $30.98 Β· Annual div: $2.00/share Β· Frequency: quarterly Β· Payout ratio: 50% Β· Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in PETQ β $102.4K in 10 years Β· $67.84/month
PetIQ, Inc. operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which include flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medications; and develops and manufactures its own proprietary value-branded products, as well as distributes third-party branded medications. It also provides OTC medications and supplies primarily within the flea and tick control, and behavior management categories of the health and wellness industry in various forms, such as spot on (topical) treatments, chewables, oral tablets, and collars. In addition, the company offers health and wellness products that include dental treats and nutritional supplements, which comprise hip and joint, vitamins, and skin and coat products. The company provides its products primarily under the PetIQ, PetArmor, VIP Petcare, VetIQ PetCare, VetIQ, Capstar, Advecta, SENTRY, Sergeants, PetLock, Heart Shield Plus, TruProfen, Betsy Farms, PetAction, Minties, Vera, and Delightibles brands. In addition, the company offers a suite of services at 2,900 community clinics and wellness centers hosted at pet retailers across 42 states, including diagnostic tests, vaccinations, prescription medications, microchipping, and wellness checks. It operates through approximately 60,000 points of distribution across veterinarian, retail, and e-commerce channels. The company was founded in 2010 and is headquartered in Eagle, Idaho.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime.
Ready to invest? Open PETQ position with:
Real after-tax yield depends on where you live and how you hold PETQ.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| πΊπΈ Roth IRA / 401k | 0% | 6.46% | 3.66% | $646 / yr |
| πΊπΈ US Taxable (15%) β | 15% | 5.49% | 2.69% | $549 / yr |
| πΊπΈ US Taxable (20%) | 20% | 5.17% | 2.37% | $517 / yr |
| π¬π§ UK ISA | 0% | 6.46% | 3.66% | $646 / yr |
| π¬π§ UK Taxable | 8.75% | 5.89% | 3.09% | $589 / yr |
| π¨π¦ TFSA | 0% | 6.46% | 3.66% | $646 / yr |
| π¨π¦ CA Taxable | 25% | 4.84% | 2.04% | $485 / yr |
| π¦πΊ Super (pension) | 15% | 5.49% | 2.69% | $549 / yr |
| π¦πΊ AU Taxable | 30% | 4.52% | 1.72% | $452 / yr |
| π©πͺ DE Taxable | 26.375% | 4.76% | 1.96% | $476 / yr |
| π«π· FR Taxable | 30% | 4.52% | 1.72% | $452 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr Β· πΊπΈ US Taxable (15%) Β· static projection (no growth assumed).
PETQ pays quarterly β 4 times per year. Next ex-div: TBD.
How PETQ compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024β2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for PETQ sourced from FMP /financial-growth endpoint β real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| A-Award | 2024-10-24 | 21,268 | β | β | ||
| D-Return | 2024-10-25 | 36,513 | $16.00 | $584.2K | ||
| D-Return | 2024-10-25 | 21,268 | β | β | ||
| D-Return | 2024-10-25 | 16,000 | $31.00 | $496.0K | ||
| D-Return | 2024-10-25 | 4,103 | β | β | ||
| D-Return | 2024-10-25 | 6,077 | $31.00 | $188.4K | ||
| A-Award | 2024-10-24 | 13,985 | β | β | ||
| D-Return | 2024-10-25 | 178 | $31.00 | $5.5K | ||
| D-Return | 2024-10-25 | 6,311 | $27.73 | $175.0K | ||
| D-Return | 2024-10-25 | 10,987 | $19.49 | $214.1K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores β lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the PETQ dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer β